US 10245259
Methods of treating RBP4 related diseases with triazolopyridines
granted A61KA61K31/4545A61K31/4985
Quick answer
US patent 10245259 (Methods of treating RBP4 related diseases with triazolopyridines) held by Belite Bio, Inc expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Belite Bio, Inc
- Grant date
- Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4545, A61K31/4985, A61K31/519, A61K31/5365